Real-World Rx 💊, Real Results 📉: GLP-1 Agents Slash HFpEF Risk
Dr RR Baliga's "Got Knowledge Doc" Podkast
September 5, 20256m 4s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
💥 Practice-Changing Evidence in HFpEF! 💥
In a real-world cohort of 97,000+ patients with obesity & type 2 diabetes, semaglutide and tirzepatide reduced risk of heart failure hospitalization or death by over 40% 📉
⚖️ No meaningful difference between the two agents.
🧠 Findings reinforce STEP-HFpEF & SUMMIT trials and highlight GLP-1 therapies' expanding role in cardiometabolic HFpEF 🫀
#Cardiology #HFpEF #GLP1 #Semaglutide #Tirzepatide #T2DM #RealWorldEvidence #JAMA #HeartFailure